76.40 +1.27 (1.69%)
After hours: 6:24PM EST
|Bid||75.55 x 3100|
|Ask||76.50 x 1000|
|Day's Range||70.89 - 79.97|
|52 Week Range||20.10 - 300.00|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||140.00|
MedMen is on the forefront of the modern cannabis industry. Yahoo Finance's Seana Smith, Adam Shapiro , and Adam Bierman, Medmen CEO discuss.
Tilray said in a press release it invested C$7.5 million ($5.6 million) in Canada-based Rose LifeScience, a producer of cannabis. "Tilray and High Park value our partnership with the SQDC and our shared commitment to creating a responsible and safe legal market for cannabis," says Adine-Fabiani Carter, Chief Marketing Officer, High Park.
HENDERSON, NV / ACCESSWIRE / December 14, 2018 / The 2018 Farm Bill was passed by the Senate on Tuesday by a vote of 87-13 and awaiting for President Donald Trump's signature. If the Farm Bill becomes law, the USDA will approve federal standards during the next year. The $867 billion Farm Bill explains that hemp will be treated as an agricultural product and will remove the plant from the Controlled Substances Act.
CORAL GABLES, FL / ACCESSWIRE / December 14, 2018 / The United States Senate and House passed the 2018 Farm Bill this week thus paving the way for CBD and hemp legalization. Hemp products are made in America, sold in America, and consumed in America.
On December 14, Tilray (TLRY) announced that it’s investing in ROSE LifeScience—a cannabis producer in Quebec. The agreement between Tilray’s subsidiary High Park Farms and ROSE LifeScience entails an exclusive sale, distribution, supply, and marketing agreement. Tilray will spend 7.5 million Canadian dollars, which accounts for 12% in capital for ROSE LifeScience.
For a long time, we’ve discussed how product differentiation will be key to the success of cannabis producers (HMMJ) in such a crowded market. Companies within the cannabis space know this very well and are making early moves to develop and acquire intellectual property rights from other companies to be able to develop unique products that may someday be a blockbuster for the companies. On December 3, Canopy Growth (WEED) announced a multiyear agreement with Valens GroWorks (MYMSF).
After the significant decline in Aphria’s (APHA) value last week, the company provided some respite to investors by purchasing shares worth $3.1 million. The company announced a special committee that consists of independent directors who will review the allegations that led Aphria’s downfall. On December 13, Aphria stock fell ~9.5% to 7.04 Canadian dollars.
International markets are becoming more important for cannabis companies (MJ). Tilray (TLRY), Aurora Cannabis (ACB), Canopy Growth (WEED), and Cronos Group (CRON) each have international operations, as you can see in the following chart.
Tilray, Inc. (TLRY), a global pioneer in cannabis production and distribution, today announced an investment in Québec-based cannabis producer, ROSE LifeScience Inc. (“ROSE”) and an exclusive sale, supply, distribution and marketing agreement between High Park Farms Ltd. (“High Park”), a wholly-owned subsidiary of Tilray, and ROSE. Tilray will subscribe for 41 Class “A” Common shares (12%) in the capital of ROSE for a subscription amount of C$7.5 million pursuant to a subscription agreement (the “Subscription Agreement”).
Wall Street is expecting good things from DAVIDsTEA's earnings after the closing bell, sending the stock soaring.
Canadian cannabis producer Tilray Inc. (NASDAQ: TLRY ) announced the formation of its International Advisory Board, which will provide guidance to the company's executive team and board of directors. The ...
On December 11, we reported that the farm bill is expected to be voted on later this week. The farm bill contained a lot of important changes. One of the most important changes that cannabis enthusiasts have been waiting for is the legislation on hemp farming. On December 12, the Senate passed the farm bill, which will have a term of five years.
On December 12, Mississauga and Markham voted against opening private cannabis retail stores for now. The Mississauga city council voted 10-2 against allowing private cannabis retail stores to operate in the city. The Markham city council voted 12-1 against opening private cannabis retail stores.
NEW YORK, NY / ACCESSWIRE / December 13, 2018 / While some marijuana stocks were getting a boost in share price as Wall Street learned that the U.S. Senate passed the farm bill, Tilray Inc. wasn't one of them. Shares of Tilray sank over 10% yesterday. Aurora Cannabis managed to close up in the green though.
Tilray, Inc. (TLRY), a global pioneer in cannabis production and distribution, today announced the formation of its International Advisory Board, an esteemed group of business and government leaders who will provide guidance to Tilray’s executive team and Board of Directors as the company pursues its aggressive global growth strategy. “We are honored to welcome this impressive group of distinguished leaders to the Tilray team,” says Brendan Kennedy, Tilray CEO.
The nation’s largest pension has mostly divested itself of tobacco and related stocks, but “Calpers” recently bought Tilray stock.
CORAL GABLES, FL / ACCESSWIRE / December 12,2018 / The United States Senate passed the 2018 Farm Bill on Tuesday thus paving the way for CBD and hemp legalization. "Hemp products are made in America, sold in America, and consumed in America. Premier Health Group (PHGRF) (PHGI) announced this week that as a part of its growth strategy to cover the major verticals associated with primary care, it has signed a binding Letter of Intent to acquire a Vancouver, British Columbia based pharmacy.
HENDERSON, NV / ACCESSWIRE / December 12, 2018 / Senate Majority Leader, Mitch McConnell, got the Twitter space buzzing when he said, "With today's signature, my provision to legalize industrial hemp ...
On December 11, New Zealand’s government made way for medical cannabis legalization. New Zealand already allowed a few patients to access medical cannabis. The new law makes medical cannabis widely accessible to more patients.
In the previous part, we discussed that nine major cannabis stocks’ (HMMJ) forward EV-to-EBITDA multiples declined nearly 26% on average to 14.9x month-over-month.